Author Claim Review

 Quick Explanation Copied

 Long Explanation

Career Arc and Citation Metrics

Andrew Rowntree's OpenAlex profile shows 10 works, 66 total citations, and an h-index of 3, with no listed primary institution — consistent with a postdoctoral-stage researcher OpenAlex profile. His output rises steadily: one work in 2014 (a University of Chester mathematical dissertation on mutualism modelling), an applied-numerics paper on discrete mutualism models in 2019, then a shift to systems/cancer biology from 2021 onward Mutualism modelling dissertation Discrete mutualism model paper.

Citations by year show clear momentum: 1 (2019), 3 (2021), 3 (2022), 3 (2023), 8 (2024), 27 (2025), and 21 already in 2026 — roughly 73% of career citations arriving in the last two years, a pattern typical of a researcher whose best work is recently published.

Key Scientific Contributions

His most-cited work, a middle-author PNAS paper (25 citations), combined endogenous Hes1 fluorescent labelling with dynamical analysis to show that phase registration of Hes1 oscillations with mitoses underlies cell-cycle length heterogeneity in ER+ breast cancer cells PNAS Hes1 phase-register paper. He then led (first-author) the mathematical counterpart, showing bilateral feedback in an oscillator model is required to explain Hes1–cell-cycle coupling dynamics Hes1 oscillator bilateral feedback model. This experimental-theory pairing across 2021–2022 demonstrates genuine interdisciplinarity: he can both build dynamical models and sit inside a wet-lab collaboration.

His 2025 first-authored-lineage work culminated in a 2026 PNAS paper showing HES1 oscillations are required for cell-cycle re-entry in ER+ breast cancer cells — a causal claim with direct relevance to dormant disseminated tumour cell reactivation and recurrence PNAS 2026 HES1 re-entry paper HES1 re-entry preprint. He is also a middle author on a Developmental Cell paper decoding NEUROGENIN3 oscillatory timing in human pancreatic endocrine differentiation (16 citations) NGN3 oscillations in pancreatic differentiation, and contributed to glioblastoma work identifying oscillatory SOX2 expression in quiescent glioblastoma stem cells SOX2 oscillations in glioblastoma, plus a methods preprint engineering tunable oscillatory protein expression using Tet-ON and dTAG degron systems Oscillatory protein expression engineering preprint.

Blindspots and Uncertainties

Known: strong collaborative embedding in the Papalopulu group at Manchester, an interdisciplinary maths-to-biology skill set, and two PNAS-tier papers within a 5-year window. Inferred: the low h-index (3) against 66 total citations indicates a few well-cited papers rather than a broad independent footprint. Uncertain/unknown: no primary institution is listed in OpenAlex; funding, grants, invited talks, and sole-corresponding-author roles are not visible in the supplied metadata, so independence cannot be assessed. All co-first/co-middle positions mean his personal contribution magnitude in high-impact papers cannot be separated from team effects from these data alone. Confidence in the bibliometric picture is high; confidence in inferring scientific depth beyond published work is moderate.

 BGPT Author Review

Scientific Quality

Early-career researcher with a credible interdisciplinary trajectory: a 2014 maths dissertation, a 2019 applied-numerics paper, then rapid ascent into high-impact systems oncology (PNAS 2021 and 2026, Developmental Cell 2025). H-index of 3 and 66 citations signal potential, not established authority. No evidence of independent funding or group leadership; nearly all high-impact work is collaborative under Papalopulu. Solid but unproven at senior level.

Communication Quality

Papers appear in top-tier venues with clear mechanistic framing (phase registration, oscillation decoding), suggesting effective cross-disciplinary communication between mathematics and experimental biology. However, communication quality cannot be fully judged from abstracts alone, and heavy MDPI Mathematics output suggests audience-limited writing in at least one venue.

Author Novelty

The Hes1-oscillation/cell-cycle phase-register concept and the requirement of HES1 oscillations for cell-cycle re-entry in dormant cancer cells are non-obvious, mechanism-level claims in an underexplored niche (oscillatory transcription factors controlling quiescence in cancer). The degron/Tet-ON oscillation engineering preprint extends this toward synthetic control. Not paradigm-shifting, but a distinctive and coherent research line.

Scientific Rigor

High reference counts (48-103), causal claims backed by endogenous knock-in reporters, and paired experimental-theoretical validation suggest careful work. However, reliance on cell-line models for cancer claims, middle-author obscurity in flagship papers, and one first-author paper in a lower-rigour MDPI venue temper the assessment. Preprint-to-PNAS consistency is a positive reproducibility signal.